New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aclarion, Inc.
ACON
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Medical - Healthcare Information Services

Next Earning date - 12 Nov 2024

2M

Medical - Healthcare Information Services

Next Earning date - 12 Nov 2024

0.17USD
Shape0.00 ( 0.18%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-69%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

98%

Quote Panel

Shape
Updated October 18, 2024
1W -2.18 % 1M -7.95 % 3M -41.28 % 1Y -98.13 %

Key Metrics

Shape
  • Market Cap

    1.71M


  • Shares Outstanding

    10.04M


  • Share in Float

    9.53M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.1703


  • Average Volume

    482515


  • Beta

    0.438


  • Range

    0.16-9.6


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.aclarion.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

31.71x

P/S Ratio

0.85x

P/B Ratio

0.5

Debt/Equity

-10937.7%

Net Margin

$-4.1

EPS

How ACON compares to sector?

P/E Ratio

Relative Strength

Shape

ACON

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$260K

Shape2270%

2025-Revenue

$0.55

Shape-263%

2025-EPS

$260K

Shape76%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Ascendiant

initialise

Previous: Not converted

2024-07-29

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.21
vs -0.38

Q4.22

arrow
arrow

N/A

NA
vs -0.38

Q1.23

arrow
arrow

N/A

-0.15
vs -0.15

Q2.23

arrow
arrow

N/A

-2.88
vs -0.49

Q3.23

arrow
arrow

N/A

NA
vs -0.21

Q4.23

arrow
arrow

N/A

-1.53
vs NA

Q1.24

arrow
arrow

N/A

-0.44
vs -0.15

Q2.24

arrow
arrow

N/A

-0.15
vs -2.88

Q3.24

arrow
arrow

N/A

-0.17
vs NA

Q4.24

arrow
arrow

N/A

-0.15
vs -1.53

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+68%

18.2K  vs 10.9K

Q4.22

arrow
arrow

+88%

22.5K  vs 12K

Q1.23

arrow
arrow

+182%

25.5K  vs 9K

Q2.23

arrow
arrow

+60%

17.1K  vs 10.7K

Q3.23

arrow
arrow

+5%

19.1K  vs 18.2K

Q4.23

arrow
arrow

-39%

13.8K  vs 22.5K

Q1.24

arrow
arrow

-60%

10.1K  vs 25.5K

Q2.24

arrow
arrow

-36%

11K  vs 17.1K

Q3.24

arrow
arrow

+31%

25K  vs 19.1K

Q4.24

arrow
arrow

+63%

22.5K  vs 13.8K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-56%

-0.56
vs -0.87

Q4.22

arrow
arrow

-74%

-0.74
vs -0.56

Q1.23

arrow
arrow

-106%

-1.06
vs -0.74

Q2.23

arrow
arrow

-14326%

-143.26
vs -1.06

Q3.23

arrow
arrow

+121%

1.21
vs -143.26

Q4.23

arrow
arrow

+174%

1.74
vs 1.21

Q1.24

arrow
arrow

-96%

-0.96
vs 1.74

Q2.24

arrow
arrow

-75%

-0.75
vs -0.96

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

7

7
vs 2

250%

Q4.22

arrow
arrow

5

5
vs 7

-29%

Q1.23

arrow
arrow

8

8
vs 5

60%

Q2.23

arrow
arrow

12

12
vs 8

50%

Q3.23

arrow
arrow

9

9
vs 12

-25%

Q4.23

arrow
arrow

9

9
vs 9

NA

Q1.24

arrow
arrow

1

1
vs 9

-89%

Q2.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News